Literature DB >> 21532635

Rheumatoid arthritis: rituximab-induced changes in type 1 IFN response correlate with outcome.

Shreeya Nanda.   

Abstract

Entities:  

Year:  2011        PMID： 21532635     DOI： 10.1038/nrrheum.2011.46

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.

Authors:  Saskia Vosslamber; Hennie G Raterman; Tineke C T M van der Pouw Kraan; Marco W J Schreurs; B Mary E von Blomberg; Michael T Nurmohamed; Willem F Lems; Ben A C Dijkmans; Alexandre E Voskuyl; Cornelis L Verweij
Journal:  Ann Rheum Dis       Date:  2011-03-27       Impact factor: 19.103
  1 in total
  1 in total

1.  CD20 antibody primes B lymphocytes for type I interferon production.

Authors:  Dongsheng Xu; Andrew Staedman; Luwen Zhang
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.